Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTP binding protein 6 (GTPBP6) is a protein encoded by the GTPBP6 gene in humans, located in the pseudoautosomal region at the end of the short arms of both the X and Y chromosomes[1][7]. This protein belongs to the general class of GTP-binding proteins, which act as molecular switches in cells through their ability to bind and hydrolyze GTP, playing crucial roles in signal transduction and other regulatory processes[2][4]. However, specific biochemical or signaling functions of GTPBP6 itself remain uncharacterized beyond GTP binding[1][3]. Mutations or overexpression of GTPBP6 have been associated with certain rare genetic conditions (such as Leri-Weill dyschondrosteosis and hypogonadotropic hypogonadism) and may play a role in the cognitive phenotype in individuals with Klinefelter syndrome, but there is no current evidence that it serves as a direct therapeutic target or has characterized interactions with small molecule drugs[1][3][7]. Additional aliases include "pseudoautosomal GTP binding protein-like"[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTP binding protein 6 (GTPBP6).